$3.73
-0.22-5.57%
Last update: Nov 9, 8:59 AM
BriaCell Therapeutics Corp
BCTXNASDAQ
The average analyst price target for BriaCell Therapeutics is $40, 905.0% above the current price. The one analyst covering it rates it Buy. The latest change came on Aug 27, 2025, when HC Wainwright & Co. raised its price target on BriaCell Therapeutics from $32 to $40 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
